由买买提看人间百态

topics

全部话题 - 话题: dose2
(共0页)
j*******1
发帖数: 266
1
来自主题: Pharmaceutical版 - FDA方法的死穴是什么?
“The sponsor aims to test the efficacy and safety of a combo drug, then it
is a combo drug. Not necessary to test the efficacy and safety of each
components. Otherwise it will be multiple applications for multiple drugs.”
I never said it necessary to test the efficacy and safety of each
components, I said that you need to test different combination from a few
NCEs in a single drug to find out safety and efficacy.
What we are debating is if development of a drug with a few NCEs costs more
or much... 阅读全帖
(共0页)